Treace to Report First Quarter 2021 Financial Results on May 25, 2021
18 May 2021 - 10:00PM
Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a
commercial-stage orthopaedic medical device company driving a
paradigm shift in the surgical treatment of Hallux Valgus (commonly
known as bunions), today announced that it will release financial
results for the first quarter of 2021 after the close of trading on
Tuesday, May 25, 2021. Company management will host a conference
call to discuss financial results beginning at 4:30 p.m. ET.
Investors interested in listening to the
conference call may do so by dialing (833) 730-3977 for domestic
callers or (720) 405-2122 for international callers, followed by
Conference ID: 1157038. A live and archived webcast of the event
will be available on the Company’s investors relations website at
https://investors.treace.com/.
About Treace Medical
ConceptsTreace Medical Concepts is a commercial-stage
orthopaedic medical device company with the goal of advancing the
standard of care for the surgical management of bunion deformities.
Bunions are complex 3-dimensional deformities that originate from
an unstable joint in the middle of the foot. Treace has pioneered
and patented the Lapiplasty® 3D Bunion Correction™ system - a
combination of instruments, implants, and surgical methods designed
to correct all 3 planes of the bunion deformity and secure the
unstable joint, addressing the root cause of the bunion and getting
patients back to their active lives quickly.
To learn more about Lapiplasty® 3D Bunion
Correction™, or find a Lapiplasty® surgeon in your area, please
visit: www.AlignMyToe.com or www.treace.com/patients.
Contacts:Treace Medical
ConceptsMark L. HairChief Financial
Officermhair@treace.net(904) 373-5940
Investors: Gilmartin GroupLynn
Lewis or Vivian CervantesIR@treace.net
Treace Medical Concepts (NASDAQ:TMCI)
Historical Stock Chart
From Apr 2024 to May 2024
Treace Medical Concepts (NASDAQ:TMCI)
Historical Stock Chart
From May 2023 to May 2024